# Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL

> **NCT00355472** · PHASE1 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Adult T-Cell Leukemia and Lymphoma (ATL)
- Adult Peripheral T-Cell Lymphoma (PTCL)

## Interventions

- **DRUG:** KW-0761

## Key facts

- **NCT ID:** NCT00355472
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00355472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00355472, "Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00355472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*